Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

Atalay G., Biganzoli L., Renard F., Paridaens R., Cufer T., Coleman R., ...Daha Fazla

European journal of cancer (Oxford, England : 1990), cilt.39, ss.2439-49, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1016/s0959-8049(03)00601-4
  • Dergi Adı: European journal of cancer (Oxford, England : 1990)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2439-49
  • Anahtar Kelimeler: breast cancer, liver metastases, HIGH-DOSE CHEMOTHERAPY, LONG-TERM SURVIVAL, PROGNOSTIC-FACTORS, COMBINATION CHEMOTHERAPY, EUROPEAN ORGANIZATION, FOLLOW-UP, DOXORUBICIN, DOCETAXEL, ESTROGEN, THERAPY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır